zeneca zd 6169 has been researched along with Urinary Incontinence in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, FJ; Ceccarelli, C; Chun, AL; Empfield, JR; Forst, JM; Frank, CA; Gibson, KH; Grant, TL; Harris, RJ; Howe, BB; Hulsizer, JM; Kau, ST; Lewis, JJ; Lin, MM; Masek, BB; Mayhugh, DR; McLaren, FM; Neilson, KL; Ohnmacht, CJ; Russell, K; Shapiro, HS; Silverman, SM; Smith, RW; Trainor, DA; Warwick, PJ | 1 |
| Antane, MM; Antane, SA; Argentieri, TM; Butera, JA; Freeden, C; Graceffa, RF; Hirth, BH; Jenkins, D; Lennox, JR; Matelan, E; Norton, NW; Quagliato, D; Sheldon, JH; Spinelli, W; Warga, D; Wojdan, A; Woods, M | 1 |
| Antane, MM; Argentieri, TM; Butera, JA; Francisco, GD; Freeden, C; Gilbert, AM; Graceffa, RF; Gundersen, EG; Herbst, D; Hirth, BH; Lennox, JR; McFarlane, G; Norton, NW; Quagliato, D; Sheldon, JH; Warga, D; Wojdan, A; Woods, M | 1 |
| Cheng, CY; Hsin, LW; Liang, PH | 1 |
| Calzadilla, SV; Cox, BF; Fryer, RM; Gopalakrishnan, M; Hu, Y; Lin, CT; Marsh, KC; Preusser, LC; Reinhart, GA; Xu, H | 1 |
5 other study(ies) available for zeneca zd 6169 and Urinary Incontinence
| Article | Year |
|---|---|
N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP potassium channel openers. Modifications on the western region.
Topics: Amides; Animals; Cricetinae; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Potassium Channels; Rats; Structure-Activity Relationship; Urinary Bladder; Urinary Incontinence | 1996 |
Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Cyclobutanes; Drug Design; Drug Evaluation, Preclinical; Female; Heart Rate; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nitriles; Patch-Clamp Techniques; Potassium Channels; Potassium Chloride; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Urinary Bladder; Urinary Incontinence | 2000 |
Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 2. Selective and potent benzylamino cyclobutenediones.
Topics: Adenosine Triphosphate; Animals; Benzylamines; Blood Pressure; Cyclobutanes; Drug Design; Drug Evaluation, Preclinical; Female; Heart Rate; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Potassium Channels; Potassium Chloride; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Urinary Bladder; Urinary Incontinence | 2000 |
N-Arylated pyrrolidin-2-ones and morpholin-3-ones as potassium channel openers.
Topics: Amides; Animals; Benzophenones; Ion Channel Gating; Male; Morpholines; Muscle Contraction; Muscle, Smooth; Portal Vein; Potassium Channels; Pyrrolidinones; Rats; Rats, Wistar; Structure-Activity Relationship; Urinary Bladder; Urinary Incontinence | 2002 |
(-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canine.
Topics: Adenosine Triphosphate; Amides; Animals; Benzophenones; Blood Pressure; Cyclic S-Oxides; Cyclobutanes; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electrocardiography; Heart Rate; Hypotension; Infusions, Intravenous; Ion Channel Gating; Male; Muscle Contraction; Muscle, Smooth; Nifedipine; Nitriles; Pharmaceutical Vehicles; Polyethylene Glycols; Potassium Channels; Quinolones; Tachycardia; Urinary Bladder; Urinary Incontinence; Vascular Resistance | 2004 |